Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of resveratrol on serum irisin and adiponectin in patients with type 2 diabetes
IRCT201601022394N19Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of resveratrol in type 2 diabetes mellitus (T2DM), sponsored by Iran University of Medical Sciences. Primary endpoints: Serum irisin level change and Serum adiponectin level change. Started Jun 2015; status: completed.
02
Drugs
resveratrol
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT201601022394N19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201601022394N19.